Q2 2026 Seer Inc Earnings Call Transcript
Key Points
- Seer Inc (SEER) reported sequential revenue growth from Q1 to Q2 2026, indicating early positive momentum under new commercial leadership.
- The company has a strong cash position of $209.5 million, providing sufficient runway to reach cash flow breakeven and support strategic investments.
- Seer Inc (SEER) has significantly expanded its scientific validation with over 95 publications, including independent studies from Roche and Nature Genetics that highlight the Proteograph's superior depth and reliability.
- The company is making progress in AI-driven proteomics, with promising early data for multi-cancer screening presented at ASMS 2026, positioning it for future growth in this emerging field.
- Seer Inc (SEER) has successfully defended its intellectual property, with key patent claims upheld by the US PTAB and European Patent Office, and an ITC investigation opened against a competitor.
- Seer Inc (SEER) experienced a year-over-year revenue decline in Q2 2026, from $4.1 million to $3.1 million, due to ongoing academic and government funding headwinds.
- The company faces elongated sales cycles in commercial accounts, as customers extend evaluations, which could delay revenue recognition.
- Gross margin decreased to 49% in Q2 2026 from 52% in the prior year, reflecting lower product sales and potential volatility in the near term.
- Seer Inc (SEER) continues to incur elevated legal and professional service expenses related to IP defense, which could pressure profitability.
- The challenging academic funding environment is expected to persist through 2026, potentially limiting growth in a key customer segment.
Good day, and welcome to the Seer, Inc. second quarter 2026 earnings conference call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Marissa Bych with Gilmartin Group. Please go ahead.
Thank you. Earlier today, Seer released financial results for the quarter ended June 30, 2026. If you have not received this news release or if you would like to be added to the company's distribution list, please send an e-mail to [email protected]. In addition, during today's conference call, we will be referencing a slide presentation that can be accessed on the Events and Presentations section of Seer's Investor Relations website. Participating today from Seer is Omid Farokhzad, Chief Executive Officer and Chair of the Board; and David Horn, Chief Financial Officer and President.
Before we begin, I would like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
